Comprehensive wearables and sensors solution, powered by the Perceptive MyTrials® Analytics platform, creates greater efficiencies for biopharmaceutical companies
LONDON, March 30, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new offering that securely captures, transmits, stores, and visualises study subject data in clinical trials.
PAREXEL’s offering, powered by the Perceptive MyTrials® Analytics platform, enables an end-to-end services and technology solution that facilitates the remote collection of study subject data via medical devices. Collection of clinical data via wearables and sensors could replace or reduce the number of clinical assessments and/or on-site visits during clinical trials.
- Published: 30 March 2017
- Written by RealWire